VivoSeq
Other

Hormone Replacement Therapy

0

Pipeline Programs↗

2

Active Trials↗

4

Companies Involved↗

Hormone Replacement Therapy is an early-stage landscape with 0 programs across 4 companies. The most active players are Novo Nordisk, Sanofi, Solvay Pharmaceuticals.

Intelligence

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

75/100

Attrition Rate

17/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Novo Nordisk logo

Novo Nordisk

0 programs

PreclinicalSanofi logo

Sanofi

0 programs

PreclinicalS

Solvay Pharmaceuticals

0 programs

PreclinicalBayer logo

Bayer

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

23

clinical trials

Completed12 · 52%
Unknown status5 · 22%
Terminated4 · 17%
Recruiting2 · 9%

Clinical Trials

Trial Activity

23 trials

The Influence of Hormone Replacement Therapy and Supervised Exercise Training on Body Composition, Cardiovascular Risk and Insulin Sensitivity in Postmenopausal Women
Recruiting·UUniversity Hospital, Ghent·N/A·NCT05831709·390 enrolled
Hydrocortisone in Hormone Replacement Therapy for Large Pituitary Neuroendocrine Tumors
Recruiting·—·Phase 4·NCT06679816·882 enrolled
Bioavailability of Three Oral Formulations for Hormone Replacement Therapy in Postmenopausal Women
Completed·Novo Nordisk logoNovo Nordisk·Phase 1·NCT01477632·24 enrolled
Impact of Professional Societies' Recommendations on Practical Use of Hormone Replacement Therapy
Completed·Novo Nordisk logoNovo Nordisk·N/A·NCT01487304·3,760 enrolled
Study to Compare the Effect of Hormone Replacement Therapy (HRT) on Breast and Cardiovascular Metabolic Markers in Postmenopausal Women
Completed·SSolvay Pharmaceuticals·Phase 4·NCT00145522·135 enrolled
Effects of Continuous Combined Hormone Replacement Therapy and Clodronate on Bone Mineral Density (BMD) in Osteoporotic Women
Completed·KKuopio University Hospital·N/A·NCT00877097·167 enrolled
Nanoparticulate Versus Micronized Steroids Delivery for Transdermal Hormone Replacement Therapy
Completed·UUniversity Potiguar·Phase 2·NCT02467673·185 enrolled
GnRH Agonist Plus Hormone Replacement Therapy vs Hormone Replacement Therapy on IVF Outcomes
Completed·TTehran University of Medical Sciences·Phase 3·NCT05189873·128 enrolled
Effects of Hormone Replacement Therapy on Inflammation and Stiffening of Artery Walls
Completed·National Heart, Lung, and Blood Institute (NHLBI)·Phase 2·NCT00005108·25 enrolled
Effects of Hormone Replacement Therapy on the Serotonergic System and Mood in Postmenopausal Women
Completed·MMedical University of Vienna·Phase 4·NCT00755963·30 enrolled
Effect of Hormone Replacement Therapy on Lupus Activity
Completed·IInstituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran·Phase 4·NCT00392093·108 enrolled
Hormone Replacement Therapy for Use in Postmenopausal Women for Relief of Hot Flushes and Urogenital Symptoms.
Completed·—·Phase 3·NCT01070979·249 enrolled
Assessment of the Transfer of Using Levonorgestrel Intrauterine System (LNG IUS) as a Contraceptive to Using it as Part of Hormone Replacement Therapy (HRT).
Completed·Bayer logoBayer·Phase 3·NCT00185458·394 enrolled
Bleeding Profile With Continuous Hormone Replacement Therapy of Activelle® in Postmenopausal Women
Completed·Novo Nordisk logoNovo Nordisk·Phase 4·NCT01705249·191 enrolled
Safety of Estrogens in Lupus: Hormone Replacement Therapy
Terminated·NNYU Langone Health·Phase 3·NCT00000419·350 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)